Overview

Remimazolam Bolus for General Anesthesia

Status:
Completed
Trial end date:
2021-07-26
Target enrollment:
Participant gender:
Summary
It is important to estimate the adequate dose of remimazolam intravenous bolus injection to induce the loss of consciousness. We will determine the ED50 and ED95 of remimazolam intravenous bolus on the loss of consciousness in patients undergoing general anesthesia.
Phase:
Phase 3
Details
Lead Sponsor:
Gangnam Severance Hospital